Full View

Economic evaluation of remdesivir for the treatment of severe COVID‐19 patients in China under different scenarios

Y Jiang, D Cai, D Chen, S Jiang, L Si… - British Journal of Clinical …, 2021 - Wiley Online Library
Aims The present study aimed to evaluate the cost‐effectiveness of the 5‐day remdesivir
regimen compared with standard of care among severe COVID‐19 patients in China, the …
被引用次数：17 相关文章

Economic evaluation of remdesivir for the treatment of severe COVID-19 patients in China under different scenarios

Y Jiang, D Cai, D Chen, S Jiang… - British journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Aims The present study aimed to evaluate the cost-effectiveness of the 5-day remdesivir
regimen compared with standard of care among severe COVID-19 patients in China, the …

Economic evaluation of remdesivir for the treatment of severe COVID-19 patients in China under different scenarios

Y Jiang, D Cai, D Chen, S Jiang… - British Journal …, 2021 - researchdirect.westernsydney.edu …
Aims: The present study aimed to evaluate the cost-effectiveness of the 5-day remdesivir
regimen compared with standard of care among severe COVID-19 patients in China, the …

Economic evaluation of remdesivir for the treatment of severe COVID‐19 patients in China under different scenarios

Y Jiang, D Cai, D Chen, S Jiang… - British Journal of …, 2021 - researchers.mq.edu.au
Aims: The present study aimed to evaluate the cost-effectiveness of the 5-day remdesivir
regimen compared with standard of care among severe COVID-19 patients in China, the …
[HTML] nih.gov

[HTML][HTML] Economic evaluation of remdesivir for the treatment of severe COVID‐19 patients in China under different scenarios

Y Jiang, D Cai, D Chen, S Jiang, L Si… - British Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Aims The present study aimed to evaluate the cost‐effectiveness of the 5‐day remdesivir
regimen compared with standard of care among severe COVID‐19 patients in China, the …

Economic evaluation of remdesivir for the treatment of severe COVID-19 patients in China under different scenarios.

Y Jiang, D Cai, D Chen, S Jiang, L Si… - British Journal of Clinical …, 2021 - europepmc.org
Aims The present study aimed to evaluate the cost-effectiveness of the 5-day remdesivir
regimen compared with standard of care among severe COVID-19 patients in China, the …

Economic evaluation of remdesivir for the treatment of severe COVID-19 patients in China under different scenarios.

Y Jiang, D Cai, D Chen, S Jiang, L Si, J Wu - 2021 - cabidigitallibrary.org
Aims: The present study aimed to evaluate the cost-effectiveness of the 5-day remdesivir
regimen compared with standard of care among severe COVID-19 patients in China, the …
[PDF] researchgate.net

[PDF][PDF] Economic evaluation of remdesivir for the treatment of severe COVID-19 patients in China under different scenarios

Y Jiang, D Cai, D Chen, S Jiang, L Si, J Wu - researchgate.net
Aims: The present study aimed to evaluate the cost-effectiveness of the 5-day remdesivir
regimen compared with standard of care among severe COVID-19 patients in China, the …

Economic evaluation of remdesivir for the treatment of severe COVID‐19 patients in China under different scenarios.

Y Jiang, D Cai, D Chen, S Jiang… - British Journal of …, 2021 - search.ebscohost.com
Aims: The present study aimed to evaluate the cost‐effectiveness of the 5‐day remdesivir
regimen compared with standard of care among severe COVID‐19 patients in China, the …